Triple Helix Discovery Engine
Potential BlockBuster Technology and/or Business Model
Pioneers: Triple Helix: New Business Models_Open Innovation, Virtual Organizations, Royalty Aggregators, Etc.
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Massachusetts

SpringLeaf Therapeutics

Parents

- Large volume biopharmaceuticals: The SpringLeaf system has a simple, elegant power source—which doubles as the actual delivery mechanism—creating a highly compact system capable of subcutaneously delivering large drug volumes (above one milliliter) that
- Patient-administered treatments: SpringLeaf’s prefilled therapeutic allows patients to self-administer treatment at home, which should reduce the need for complicated and expensive delivery systems, multiple injections and/or visits to an outpatient cent
- Viscous drugs: SpringLeaf’s therapies incorporate the Company’s powerful, internally driven morphing surface, which generates a considerable amount of force in a small package to deliver highly viscous biopharmaceuticals and other drugs.
Boston, Massachusetts
Excel Venture Management joins prior investors SR One, Flybridge Capital Partners, and North Bridge Venture Partners.
SpringLeaf Therapeutics , Series B $15M by OnBioVC (2011)
SpringLeaf Therapeutics Jumps on 4 Million More for Series B (2011)
SpringLeaf's technology is designed to expand availability of biologic therapeutics by meeting specific patient needs and enabling self-administration, which may significantly lower treatment costs and improve outcomes.
The Company has secured an additional $4 million from new investor Excel Venture Management, bringing the total round to $19 million.